A Study of ASP8302 in Participants With Underactive Bladder
Status:
Completed
Trial end date:
2020-04-28
Target enrollment:
Participant gender:
Summary
The study objectives of this study are to evaluate the efficacy of ASP8302 compared with
placebo in participants with underactive bladder (UAB), to investigate the safety and
tolerability of ASP8302 compared with placebo in participants with UAB, to investigate the
pharmacokinetics of ASP8302 in participants with UAB and to support the development of the
UAB - Patient Reported Outcome (PRO).